Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Open-angle GlaucomaOcular Hypertension

Interventions

DRUG

Travoprost 0.004% / Timolol maleate 0.5%

Solution, morning dosing

DRUG

Travoprost 0.004% / Timolol maleate 0.5%

Solution, evening dosing

Trial Locations (1)

Western Eye Hospital, London